3.00
0.23 (8.3%)
0.23 (8.3%)
Upgrade to Real-Time
Afterhours (Closed)
Low
1.842
High
4.89
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Protagenic Therapeutics Inc | PTIX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.23 | 8.3% | 3.00 | 19:59:57 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.81 | 2.80 | 3.14 | 3.06 | 2.77 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.00 | 3.07 | 0.07 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,722 | 1,924,670 | $ 2.99 | $ 5,758,699 | 4,326,009 | 1.842 - 4.89 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:57 | formt | 1,500 | $ 3.00 | USD |
Protagenic Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 43.93M | 14.64M | 11.93M | $ - | $ - | -0.26 | -8.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 32.00k | 30.20% |
Protagenic Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTIX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.79 | 3.73 | 2.621 | 3.09 | 3,887,554 | 0.21 | 7.53% |
| 1 Month | 2.98 | 4.19 | 2.16 | 2.85 | 4,279,008 | 0.02 | 0.67% |
| 3 Months | 2.75 | 4.89 | 1.842 | 3.08 | 6,589,915 | 0.25 | 9.09% |
| 6 Months | 2.75 | 4.89 | 1.842 | 3.08 | 6,589,915 | 0.25 | 9.09% |
| 1 Year | 2.75 | 4.89 | 1.842 | 3.08 | 6,589,915 | 0.25 | 9.09% |
| 3 Years | 2.75 | 4.89 | 1.842 | 3.08 | 6,589,915 | 0.25 | 9.09% |
| 5 Years | 2.75 | 4.89 | 1.842 | 3.08 | 6,589,915 | 0.25 | 9.09% |
Protagenic Therapeutics Description
| Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. |
